Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News TCT 2025

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

Caitlin E. Cox

November 06, 2025

Presentation TCT 2025

TCT 595: Cardiac Damage Staging in Moderate or Greater Aortic Regurgitation: A New Framework for Risk Stratification

Presenter: Francisco Alexandrino

October 27, 2025

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

Todd Neale

October 25, 2025

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

Presentation TCT 2024

Keynote Lecture I: Rationale for Earlier Intervention in Aortic Stenosis: The Cardiac Damage Concept and Beyond

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 643: Cost Associated With the Extent of Cardiac Damage After Aortic Valve Replacement

Presenter: Philippe Genereux

October 29, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

Presentation TCT 2023

TCT 496: Artificial Intelligence-Enabled Phenotyping of Patients with Severe Mitral Regurgitation: on the Recovery of Extra-Mitral Valve Cardiac Damage after Transcatheter Edge-to-Edge Repair

Presenter: Elena Rippen

October 26, 2023

Presentation TCT 2023

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Daijiro Tomii

October 26, 2023

Presentation TCT 2023

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Presenter: Omar Abdelfattah

October 26, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

Presentation TCT 2023

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Presenter: Josep Rodés-Cabau

October 24, 2023

Presentation TCT 2023

Moderate AS With Cardiac Damage: The PROGRESS Trial

Presenter: Raj Makkar

October 24, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News Conference News TCT 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Michael O'Riordan

October 07, 2021

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

Advertisement

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

TCT 595: Cardiac Damage Staging in Moderate or Greater Aortic Regurgitation: A New Framework for Risk Stratification

TTVR Remains Safe, Effective in Presence of CIED Leads

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

Keynote Lecture I: Rationale for Earlier Intervention in Aortic Stenosis: The Cardiac Damage Concept and Beyond

TCT 643: Cost Associated With the Extent of Cardiac Damage After Aortic Valve Replacement

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

TCT 496: Artificial Intelligence-Enabled Phenotyping of Patients with Severe Mitral Regurgitation: on the Recovery of Extra-Mitral Valve Cardiac Damage after Transcatheter Edge-to-Edge Repair

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Moderate AS With Cardiac Damage: The PROGRESS Trial

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Failed MitraClip Is Uncommon, but Bleak When It Happens

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content